Current Trends and Future Prospects of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma

In recent years, advances in drug therapy for head and neck squamous cell carcinoma (HNSCC) have progressed rapidly. In addition to cytotoxic anti-cancer agents such as platinum-based drug (cisplatin and carboplatin) and taxane-based drugs (docetaxel and paclitaxel), epidermal growth factor receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitamura, Naoya, Sento, Shinya, Yoshizawa, Yasumasa, Sasabe, Eri, Kudo, Yasusei, Yamamoto, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795499/
https://www.ncbi.nlm.nih.gov/pubmed/33383632
http://dx.doi.org/10.3390/ijms22010240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795499/
https://www.ncbi.nlm.nih.gov/pubmed/33383632
http://dx.doi.org/10.3390/ijms22010240

Ejemplares similares